References
- Grobner T. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006; 21: 1104–8
- Thomsen HS, Markmann P, Logager VB. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 2007; 7: 130–7
- Sieber M, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann H. An animal model for nephrogenic systemic fibrosis and the possible role of gadolinium. Invest Radiol 2008; 43: 65–75
- Edward, M, Quinn, JA, Mukherjee, S, Jensen, M-BV, Jardine, AG, Mark, PB, et al. Gadodiamide contrast “activates” fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 2008; DOI: 10.1002/path.2311.